Efficacy of Oral Hygiene Regimens in Patients Undergoing Non-Surgical Periodontal Treatment
PEREG
Efficacy of Multi-component Oral Hygiene Regimens in Patients Undergoing Non-surgical Periodontal Treatment: a Multicentered Randomized Clinical Trial.
1 other identifier
interventional
100
1 country
2
Brief Summary
The objective of this clinical study is to evaluate the efficacy of multi-component oral hygiene regimens as adjunctive to non-surgical periodontal treatment in patients with stage II periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Sep 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2028
September 3, 2026
August 1, 2026
1.6 years
August 31, 2026
August 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pocket depth (PD) reduction
The distance measured between the gingival margin and the bottom of the gingival sulcus or the periodontal pocket, assessed at six sites per tooth using a calibrated periodontal probe.
Baseline, 3 months, 6 months, 9 months, and 12 months post-treatment
Secondary Outcomes (7)
Change in Gingival Index (GI)
Baseline, 3 weeks, 3 months, 6 months, 9 months, and 12 months post-treatment
Change in Plaque Index (PI)
Baseline, 3 weeks, 3 months, 6 months, 9 months, and 12 months post-treatment
Clinical Attachment Level (CAL) gain
Baseline, 3 months, 6 months, 9 months, and 12 months post-treatment
Change in Bleeding on Probing (BOP)
Baseline, 3 months, 6 months, 9 months, and 12 months post-treatment
Number of residual pockets
3 months, 6 months, 9 months, and 12 months post-treatment
- +2 more secondary outcomes
Study Arms (2)
Test Group
EXPERIMENTALParticipants receive non-surgical periodontal treatment followed by an adjunctive oral hygiene regimen (Regimen I) consisting of a chlorhexidine mouthwash, stannous fluoride toothpaste, toothbrush, and floss for 3 weeks. Afterward, they switch to Regimen II consisting of a CPC/Zinc Lactate mouthwash, stannous fluoride toothpaste, toothbrush, and floss.
Negative Control Group
PLACEBO COMPARATORParticipants receive non-surgical periodontal treatment followed by an adjunctive oral hygiene regimen consisting of a fluoride placebo mouthwash, standard fluoride toothpaste, toothbrush, and floss for the duration of the study.
Interventions
Participants use a fluoride placebo mouthwash, standard fluoride toothpaste, soft bristle toothbrush, and dental floss for the duration of the study.
Participants use a 0.12% chlorhexidine mouthwash and stannous fluoride toothpaste for 3 weeks (Regimen I). Afterwards, they switch to a 0.09% CPC and 0.28% Zinc Lactate mouthwash with fluoride and stannous fluoride toothpaste (Regimen II). Both regimens include a soft bristle toothbrush and dental floss.
Eligibility Criteria
You may qualify if:
- Males and females, between 30-70 years of age, inclusive.
- Good general health. Minimum of 15 uncrowned permanent natural teeth (excluding third molars and crowns).
- Clinical diagnosis of stage II generalized periodontitis.
You may not qualify if:
- Periodontal treatment undergone 3 months before the beginning of the study. - Mucosal oral pathology.
- Uncontrolled systemic chronic disease that may interfere with host response. - Use of anti-inflammatory and antibiotic within 3 months prior to the start of the study, scheduled to start such intake during the treatment phase, or use of therapeutic mouthwash within the last three months.
- Need for antibiotic prophylaxis.
- Participation in any other clinical study.
- Pregnant, breastfeeding, or intended to get pregnant during the study.
- Allergic to oral care products, personal care consumer products, or their ingredients.
- Ongoing use of medications known to affect the gingival tissues (e.g., calcium channel blockers, phenytoin, cyclosporine).
- Current smokers and subjects with a history of alcohol or drug abuse. - Orthodontic appliances or presence of fixed or removable prosthodontics dentures that may interfere with the evaluations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Federal University of Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, 90035-003, Brazil
University of São Paulo, School of Dentistry
São Paulo, São Paulo, 90035-003, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- All products will be covered with white over-wrapping in order to conceal product identity. The examining dentist and their staff will remain blinded to product assignments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2026
First Posted
September 3, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
March 30, 2028
Study Completion (Estimated)
April 30, 2028
Last Updated
September 3, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share